Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             146 results found
no title author magazine year volume issue page(s) type
1 Abnormal heart rate variability in adults with symptomatic growth hormone (GH) deficiency: improvement after 3 months of GH replacement therapy Leong, K.S.
 2000
 53-54 S2 p. S149-
1 p.
 article
2 Acromegaly and primary hyperparathyroidism with multiple cancers of the lung, thyroid and breast: A case report Miyachi, Y.
 2000
 53-54 S2 p. S155-
1 p.
 article
3 Acromegaly caused by ectopic growth hormone-releasinghormone secretion Bonnin, C.
 2000
 53-54 S2 p. S157-
1 p.
 article
4 Adult patients with Prader-Willi syndrome: Clinical characteristics, life circumstances and growth hormone secretion Partsch, C.A.
 2000
 53-54 S2 p. S81-S85
5 p.
 article
5 An epidemiological survey of 783 patients who underwent pituitary surgery in a single centre over a 25-year period Beckers, A.
 1998
 53-54 S2 p. 188-
1 p.
 article
6 Assessment of growth hormone status in acromegaly: What biochemical markers to measure and how? Camacho-Hübner, C.
 2000
 53-54 S2 p. S125-S129
5 p.
 article
7 A study of adult hypopituitarism in Northern Ireland: Results of a prolonged follow-up of 338 patients show increased mortality in both men and women McConnell, E.M.
 2000
 53-54 S2 p. S137-
1 p.
 article
8 A switch from oral to transdermal 17β-oestradiol increases serum levels of insulin-like growth factor I in women with growth hormone (GH) deficiency receiving GH replacement therapy Janssen, Y.J.H.
 2000
 53-54 S2 p. S133-
1 p.
 article
9 Binding sites for growth hormone-releasing peptide Ong, H.
 1998
 53-54 S2 p. 137-140
4 p.
 article
10 Body composition analyses in adults with growth hormone deficiency following growth hormone therapy Davies, J.S.
 1998
 53-54 S2 p. 191-
1 p.
 article
11 Cerebrovascular deaths in patients who underwent surgery and irradiation for a pituitary tumour Erfurth, E.M.
 2000
 53-54 S2 p. S154-
1 p.
 article
12 Childhood- and adult-onset growth hormonedeficiency: Differences in cardiac function patterns in adults Boquete, H.
 2000
 53-54 S2 p. S148-
1 p.
 article
13 Cognitive dysfunction in women withhypopituitarism Bülow, B.
 2000
 53-54 S2 p. S136-
1 p.
 article
14 Combined Cushing's syndrome and acromegaly due to ectopic production of adrenocorticotropic hormone and growth hormone-releasing hormone Jansson, J.-O.
 2000
 53-54 S2 p. S157-
1 p.
 article
15 Comparison of different methods for assessing growth hormone deficiency in adults with pituitary disorders Springer, W.
 1998
 53-54 S2 p. 188-
1 p.
 article
16 Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency Sönksen, P.H.
 1998
 53-54 S2 p. 89-92
4 p.
 article
17 Contaminantminduced endocrinedisruption in wildlife Guillette Jr, L.J.
 2000
 53-54 S2 p. S45-S50
6 p.
 article
18 Cost-of-illness study of adults with hypopituitarism Ehrnborg, C.
 1998
 53-54 S2 p. 187-
1 p.
 article
19 Decreased plasma cholesterol esterificationand cholesteryl ester transfer in patients with hypopituitarism receiving glucocorticoid replacement therapy Beentjes, J.A.M.
 2000
 53-54 S2 p. S145-
1 p.
 article
20 Determinants for body image and coping inpatients with Turner syndrome Haverkamp, F.
 2000
 53-54 S2 p. S165-
1 p.
 article
21 Does desensitization to hexarelin occur? Rahim, A.
 1998
 53-54 S2 p. 141-143
3 p.
 article
22 Does the age at onset of growth hormonedeficiency have an impact on cardiac performance? Colao, A.
 2000
 53-54 S2 p. S151-
1 p.
 article
23 Effect of growth hormone deficiency on prostate size Colao, A.
 2000
 53-54 S2 p. S155-
1 p.
 article
24 Effect of growth hormone (GH) therapy andinsulin-like growth factor I on lung function and maximal oxygen consumption in children with GH deficiency Chaussain, M.
 2000
 53-54 S2 p. S150-
1 p.
 article
25 Effect of growth hormone treatment in patients with chronic fatigue syndrome: A preliminary study Moorkens, G.
 1998
 53-54 S2 p. 131-133
3 p.
 article
26 Effect of zinc administration on insulin-likegrowth factor I, haemoglobin and neonatal birth weight in pregnant women Nishiyama, S.
 2000
 53-54 S2 p. S159-
1 p.
 article
27 Effects of growth hormone and insulin-like growth factor I in experimental heart failure Ross Jr, J.
 1998
 53-54 S2 p. 159-161
3 p.
 article
28 Effects of growth hormone (GH) therapy on bone metabolism in patients with adult-onset GH deficiency: A 2-year randomized, controlled trial Bex, M.
 2000
 53-54 S2 p. S160-
1 p.
 article
29 Effects of growth hormone on boneand muscle Lissett, C.A.
 2000
 53-54 S2 p. S95-S101
7 p.
 article
30 Effects of growth hormone replacement therapy on bone mineral density and body composition in adults with growth hormone deficiency Peñafiel, J.
 1998
 53-54 S2 p. 195-
1 p.
 article
31 Effects of growth hormone therapy on cardiac and respiratory functions in growth hormone-deficient adults Taşan, E.
 1998
 53-54 S2 p. 199-
1 p.
 article
32 Effects of growth hormone treatmentin children with Prader-Willi syndrome Lee, P.D.K.
 2000
 53-54 S2 p. S75-S79
5 p.
 article
33 Effects of growth hormone treatment on visceral adipose tissue Brummer, R.-J.M.
 1998
 53-54 S2 p. 19-23
5 p.
 article
34 Effects of 18 months of growth hormone replacement therapy on bone metabolism in adults with growth hormone deficiency Kaldrymidis, Ph.
 1998
 53-54 S2 p. 195-
1 p.
 article
35 Effects of 18 months of growth hormone treatment on the lipid profile of adults with growth hormone deficiency Alexopoulou, O.
 1998
 53-54 S2 p. 200-
1 p.
 article
36 Effects of recombinant human growth hormone in catabolic adults with chronic renal failure Mehls, O.
 2000
 53-54 S2 p. S31-S37
7 p.
 article
37 Effects of the growth hormone (GH) secretagogueipamorelin on body weight gain in GH-deficient lit/lit mice Dickson, S.L.
 2000
 53-54 S2 p. S169-
1 p.
 article
38 Endothelial dysfunction in growth hormone-deficient adults Evans, L.M.
 1998
 53-54 S2 p. 200-
1 p.
 article
39 Fertile Turner syndrome and gonadotropin-producing pituitary macroadenoma Ojima, M.
 2000
 53-54 S2 p. S166-
1 p.
 article
40 Follow-up of treated acromegaly: Similarities and differences in assessing the response to different primary treatment modalities Sheppard, M.C.
 2000
 53-54 S2 p. S115-S118
4 p.
 article
41 Foreword Baumann, Gerhard
 2000
 53-54 S2 p. iii-
1 p.
 article
42 Foreword Bouillon, Roger
 1998
 53-54 S2 p. iii-
1 p.
 article
43 Four years of growth hormone replacement in adults with growth hormone deficiency: further increase in bone mineral density Johannsson, G.
 1998
 53-54 S2 p. 194-
1 p.
 article
44 From caveman cuisine to fast food: the evolution of human nutrition Bogin, B.
 1998
 53-54 S2 p. 79-86
8 p.
 article
45 Gender differences in rat hepaticCYP2C gene expression — regulation by growth hormone Mode, A.
 1998
 53-54 S2 p. 61-67
7 p.
 article
46 Gene analysis of PROP1 in dwarfism with combined pituitary hormone deficiency Takamura, Noboru
 1999
 53-54 S2 p. 12-17
6 p.
 article
47 Genetics of visceral obesity and insulin resistance: relationship to non-insulin-dependent diabetes mellitus Groop, L.
 1998
 53-54 S2 p. 9-14
6 p.
 article
48 Growth factors and insulin-like growth factor binding proteins in acute wound fluid Vogt, P.M.
 1998
 53-54 S2 p. 107-109
3 p.
 article
49 Growth hormone and ageing Johannsson, G.
 2000
 53-54 S2 p. S25-S30
6 p.
 article
50 Growth hormone and insulin-like growth factor I improve cardiac function and regulate expression of the Fas receptor in rats after experimental myocardial infarction Tivesten, Å.
 1998
 53-54 S2 p. 201-
1 p.
 article
51 Growth hormone as additional treatment for patients with chronic congestive heart failure: A review Bergh, C.-H.
 1998
 53-54 S2 p. 171-173
3 p.
 article
52 Growth hormone, burns and tissue healing Lal, S.O.
 2000
 53-54 S2 p. S39-S43
5 p.
 article
53 Growth hormone (GH) replacement therapy for1 year does not alter colonic epithelial cell proliferation in GH-deficient adults Beentjes, J.A.M.
 2000
 53-54 S2 p. S156-
1 p.
 article
54 Growth hormone inhibits renal and hepatic 11β-hydroxysteroid dehydrogenases in man Walker, B.R.
 1998
 53-54 S2 p. 194-
1 p.
 article
55 Growth hormone, insulin-like growthfactor I and cognitive function in adults van Dam, P.S.
 2000
 53-54 S2 p. S69-S73
5 p.
 article
56 Growth hormone, insulin-like growthfactor I and the CNS: Localization, function and mechanism of action Lobiezz, P.E.
 2000
 53-54 S2 p. S51-S56
6 p.
 article
57 Growth hormone replacement therapy during transition of patients with childhood-onset growth hormone deficiency into adulthood: What are the issues? Shalet, S.M.
 1998
 53-54 S2 p. 177-184
8 p.
 article
58 Growth hormone replacement therapy in adult with growth hormone deficiency: effects on body composition and body mass index after 18 months of treatment Alexopoulou, O.
 1998
 53-54 S2 p. 191-
1 p.
 article
59 Growth hormone secretagogues as corticotrophin-releasing factors Ghigo, E.
 1998
 53-54 S2 p. 145-148
4 p.
 article
60 Growth hormone suppresses thymidine uptake and secretion of insulin-like growth factor I in stimulated mouse splenocytes Kim, S.-W.
 1998
 53-54 S2 p. 206-
1 p.
 article
61 Growth hormone therapy for Prader-Willi and Down syndromes: A post-modern medical dilemma Lantos, J.D.
 2000
 53-54 S2 p. S93-S94
2 p.
 article
62 Growth hormone therapy improves body composition in adults with Prader-Willi syndrome: A preliminary report Höybye, C.
 2000
 53-54 S2 p. S139-
1 p.
 article
63 Growth hormone therapy in youngchildren with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes Annerén, G.
 2000
 53-54 S2 p. S87-S91
5 p.
 article
64 Growth hormone treatment in catabolic states other than burns Wolf, S.E.
 1998
 53-54 S2 p. 117-119
3 p.
 article
65 Growth hormone treatment in children with growth hormone deficiency Morino, M.
 1998
 53-54 S2 p. 196-
1 p.
 article
66 Growth hormone treatment of post-menopausalwomen with osteoporosis Landin-Wilhelmsen, K.
 2000
 53-54 S2 p. S161-
1 p.
 article
67 Growth in Japanese children receiving peritoneal dialysis Wada, N.
 2000
 53-54 S2 p. S164-
1 p.
 article
68 Growth patterns and skeletal features in patientswith pseudouatosomal deletions involving the SHOX gene Ono, T.
 2000
 53-54 S2 p. S171-
1 p.
 article
69 Gs alpha mutations and their clinicalmanifestations in acromegaly Susaki, N.
 2000
 53-54 S2 p. S172-
1 p.
 article
70 Haemorrheology of growth hormone-deficient adults Brun, J.F.
 1998
 53-54 S2 p. 199-
1 p.
 article
71 Hepatocyte-stimulated expression of hepatocyte growth factor in cultured hepatic stellate cells Skrtic, S.
 1998
 53-54 S2 p. 205-
1 p.
 article
72 Hereditary isolated growth hormone deficiency caused by GH1 gene mutations in Japanese patients Kamijo, Takashi
 1999
 53-54 S2 p. 31-36
6 p.
 article
73 Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats Berti, F.
 1998
 53-54 S2 p. 149-152
4 p.
 article
74 Hexarelin-stimulated growth hormone secretion in patients on maintenance haemodialysis Jenkins, R.C.
 1998
 53-54 S2 p. 198-
1 p.
 article
75 Hormonal changes during growth hormone replacement therapy: Gender-related differences Krzyzanowska, B.
 2000
 53-54 S2 p. S135-
1 p.
 article
76 Hormonal regulation of visceraladipose tissue Björntorp, P.
 1998
 53-54 S2 p. 15-17
3 p.
 article
77 Hypothalamic-pituitary tumour surveillance imaging in patients receiving growth hormone replacement Drake, W.M.
 2000
 53-54 S2 p. S153-
1 p.
 article
78 Inflammatory cytokines and acquiredgrowth hormone resistance von Laue, S.
 2000
 53-54 S2 p. S9-S14
6 p.
 article
79 Influence of gender and gonadal steroids on responsiveness to growth hormone replacement therapy in adults with growth hormone deficiency Johannsson, G.
 1998
 53-54 S2 p. 69-75
7 p.
 article
80 Inhibitory effect of growth hormone on leptinexpression in the fat tissues of fatty Zucker rats Tsushima, T.
 2000
 53-54 S2 p. S171-
1 p.
 article
81 Insulin-like growth factor I and bone: From mouse to man Beamer, W.G.
 2000
 53-54 S2 p. S103-S105
3 p.
 article
82 Insulin-like growth factor I and cardiac performance in heart failure Donath, M.Y.
 1998
 53-54 S2 p. 167-170
4 p.
 article
83 Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: Effects of rhIGFmi therapy Camacho-Hübner, Cecilia
 1999
 53-54 S2 p. 47-52
6 p.
 article
84 Insulin-like growth factor I in hypercatabolic states Gore, D.C.
 1998
 53-54 S2 p. 115-116
2 p.
 article
85 Insulin-like growth factor signalling pathways inrat hepatic stellate cells are important for DNA synthesis and hepatocyte growth factor production Skrtic, S.
 2000
 53-54 S2 p. S168-
1 p.
 article
86 Insulin sensitivity in adults with growth hormone deficiency: effects of 12 months of growth hormone replacement therapy Sinay, I.
 1998
 53-54 S2 p. 192-
1 p.
 article
87 Interrelationships between growthhormone and sleep Van Cauter, E.
 2000
 53-54 S2 p. S57-S62
6 p.
 article
88 Introduction Chihara, Kazuo
 1999
 53-54 S2 p. 1-
1 p.
 article
89 In vitro studies of insulin-like growthfactor I and bone Conover, C.A.
 2000
 53-54 S2 p. S107-S110
4 p.
 article
90 Is there a role for growth hormone in the clinical management of burn injuries? Ramirez, R.J.
 1998
 53-54 S2 p. 99-105
7 p.
 article
91 Left ventricular perfusion in acromegalic patients assessed using single-photon emission computed tomography Gryczyńska, M.
 1998
 53-54 S2 p. 201-
1 p.
 article
92 Levels of circulating plasma hepatocyte growth factor are increased in interleukin-6-deficient mice after partial hepatectomy Wallenius, V.R.
 1998
 53-54 S2 p. 203-
1 p.
 article
93 Liver-derived insulin-like growth factor I is aregulator of the growth hormone secretion pattern in mice Wallenius, K.
 2000
 53-54 S2 p. S168-
1 p.
 article
94 Long-standing growth hormone (GH) deficiency after pituitary ablation in type 1 diabetes mellitus: Experience with GH replacement therapy Simpson, H.L.
 2000
 53-54 S2 p. S163-
1 p.
 article
95 Long-term growth hormone therapy and glucose tolerance Ueyama, N.
 2000
 53-54 S2 p. S140-
1 p.
 article
96 Long-term therapy with insulin-like growth factorI normalizes glucose metabolism and growth retardation in a patient with leprechaunism Abe, S.
 2000
 53-54 S2 p. S163-
1 p.
 article
97 Low-dose growth hormone (GH) replacement therapy improves vascular reactivity in adults with GH deficiency Christ, E.R.
 2000
 53-54 S2 p. S152-
1 p.
 article
98 Muscle volume, strength and bioenergetics in adults with growth hormone deficiency Janssen, Y.J.H.
 1998
 53-54 S2 p. 187-
1 p.
 article
99 Mutations in the growth hormonereleasing hormone receptor: a new form of dwarfism in humans Baumann, Gerhard
 1999
 53-54 S2 p. 24-30
7 p.
 article
100 Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender Veldhuis, J.D.
 1998
 53-54 S2 p. 49-59
11 p.
 article
101 Pathogenesis of chronic fatigue syndrome and fibromyalgia Klimas, N.
 1998
 53-54 S2 p. 123-126
4 p.
 article
102 Pegvisomant: A growth hormonereceptor antagonist for the treatment of acromegaly Parkinson, C.
 2000
 53-54 S2 p. S119-S123
5 p.
 article
103 PIT1 abnormality Tatsumi, Ke-ita
 1999
 53-54 S2 p. 18-23
6 p.
 article
104 Plasma concentrations of free insulin-like growth factor I are normal in children with simple obesity Hasegawa, T.
 1998
 53-54 S2 p. 203-
1 p.
 article
105 Prediction of response to growth hormone treatment in adults with growth hormone deficiency Wallace, J.D.
 1998
 53-54 S2 p. 193-
1 p.
 article
106 Pulsatility of growth hormone (GH) signalling in liver cells: Role of the JAK-STAT5b pathway in GH action Choi, H.K.
 2000
 53-54 S2 p. S1-S8
8 p.
 article
107 Recombinant human growth hormone administration in multitrauma patients: effect on nitrogen balance Botsios, D.
 1998
 53-54 S2 p. 197-
1 p.
 article
108 Reduction in normal liver growth in interleukin-6-deficientmice Wallenius, V.
 2000
 53-54 S2 p. S167-
1 p.
 article
109 Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors Groner, B.
 2000
 53-54 S2 p. S15-S20
6 p.
 article
110 Relationship between the growth hormone-insulin-like growth factor I axis and serum leptin in patients with chronic renal failure Cordido, F.
 2000
 53-54 S2 p. S162-
1 p.
 article
111 Relationships between carbohydrate-lipid oxidation balance during exercise and the growth hormone-insulin-like growth factor I (IGF-I)-IGF-binding protein axis in trained athletes Brun, J.F.
 2000
 53-54 S2 p. S147-
1 p.
 article
112 Relationships between insulin-like growth factor I status and blood rheology in athletes Brun, J.F.
 2000
 53-54 S2 p. S146-
1 p.
 article
113 Responsiveness to growth hormone treatment is similar in patients with isolated growth hormone deficiency and those with multiple pituitary hormone deficiencies Burman, P.
 1998
 53-54 S2 p. 192-
1 p.
 article
114 Role of nitric oxide in the haemodynamic effects of growth hormone Böger, R.H.
 1998
 53-54 S2 p. 163-165
3 p.
 article
115 Secretion of growth hormone in patients with chronic fatigue syndrome Berwaerts, J.
 1998
 53-54 S2 p. 127-129
3 p.
 article
116 Serum growth hormone (GH)-binding proteincan predict the lipolytic and anabolic effects of GH treatment combined with diet restriction in obesity Nam, S.Y.
 2000
 53-54 S2 p. S141-
1 p.
 article
117 Serum leptin in growth hormone-deficient adults: Relationship to body composition and gender effects Páramo, C.
 2000
 53-54 S2 p. S142-
1 p.
 article
118 Serum levels of intact osteocalcin in newborn infants Takase, M.
 1998
 53-54 S2 p. 204-
1 p.
 article
119 Serum levels of leptin and their relationship with body composition in elderly individuals Erfurth, E.M.
 1998
 53-54 S2 p. 202-
1 p.
 article
120 Sex differences in growth hormone secretion and action in the rat Robinson, I.C.A.F.
 1998
 53-54 S2 p. 39-47
9 p.
 article
121 Short stature by mutant growth hormones Takahashi, Yutaka
 1999
 53-54 S2 p. 37-41
5 p.
 article
122 SHOX: pseudoautosomalhomeobox containing gene for short stature and dyschondrosteosis Ogata, Tsutomu
 1999
 53-54 S2 p. 53-58
6 p.
 article
123 Side-effects of growth hormone treatment in hypopituitary adults: experience from 613 patient-years in a single centre Wirén, L.
 1998
 53-54 S2 p. 196-
1 p.
 article
124 Similar response to growth hormone (GH)replacement therapy in men and women when the dose of GH is individualized Koranyi, J.
 2000
 53-54 S2 p. S134-
1 p.
 article
125 Stimulated growth hormone secretion in elderly men after reduction of free fatty acids by acipimox van Dam, P.S.
 2000
 53-54 S2 p. S138-
1 p.
 article
126 Studies of high-density lipoprotein kinetics in growth hormone-deficient patients with hypopituitarism Kearney, T.
 2000
 53-54 S2 p. S143-
1 p.
 article
127 Summary Chihara, Kazuo
 1999
 53-54 S2 p. 59-60
2 p.
 article
128 The acid-labile subunit of the 150-kDa insulin-likegrowth factor complex in the evaluation of growth hormone deficiency Garrone, S.
 2000
 53-54 S2 p. S158-
1 p.
 article
129 The CCAAT/enhancer-binding protein-α is expressed in the germinal layer of the growth plate: co-localization with the growth hormone receptor Vidal, N.O.A.
 1998
 53-54 S2 p. 205-
1 p.
 article
130 The circadian rhythm of leptin is preserved in patients with hypopituitarism Kousta, E.
 1998
 53-54 S2 p. 189-
1 p.
 article
131 The effects of growth hormone (GH) oncyclophosphamide-induced testicular dysfunction in GH-deficient rats Ohta, M.
 2000
 53-54 S2 p. S170-
1 p.
 article
132 The GH receptor and GH insensitivity Ross, Richard J.M.
 1999
 53-54 S2 p. 42-46
5 p.
 article
133 The growth hormone-insulin-like growth factor I axis in adults with inflammatory bowel disease Tschöp, M.
 1998
 53-54 S2 p. 197-198
2 p.
 article
134 The influence of growth hormone on glucagon-like peptide 1 secretion in hypophysectomized rats Kitayama, N.
 2000
 53-54 S2 p. S172-
1 p.
 article
135 Theoretical considerations in estimating the growth hormone axis in adults Garcia-Mayor, R.V.
 1998
 53-54 S2 p. 93-96
4 p.
 article
136 The psychological consequences and quality of life in adults with growth hormone deficiency McGauley, G.
 2000
 53-54 S2 p. S63-S68
6 p.
 article
137 The question of a link between insulin-like growth factor physiology and neoplasia Pollak, M.
 2000
 53-54 S2 p. S21-S24
4 p.
 article
138 The role of altered high-density lipoproteins in the low plasma lecithin cholesterol acyltransferase and lipid transfer protein activity found in growth hormone-deficient men with acromegaly Beentjes, J.A.M.
 2000
 53-54 S2 p. S144-
1 p.
 article
139 The somatotrophic axis in critical illness: Effects of growth hormone secretagogues Van den Berghe, G.
 1998
 53-54 S2 p. 153-155
3 p.
 article
140 The use of growth hormone in adults: a review of the last 10 years, the present and a perspective for the future Bengtsson, B.-Å.
 1998
 53-54 S2 p. 27-35
9 p.
 article
141 The use of longmacting somatostatinanalogues in acrornegaly Jenkins, P.J.
 2000
 53-54 S2 p. S111-S114
4 p.
 article
142 Tissue-specific effects of growth hormone on protein metabolism Wernerman, J.
 1998
 53-54 S2 p. 111-113
3 p.
 article
143 Transcription factors regulating pituitary development Parks, John S.
 1999
 53-54 S2 p. 2-11
10 p.
 article
144 Turnover of very low-density lipoprotein apolipoprotein B100 in growth hormone-deficient adults and control individuals Chrisoulidou, A.
 1998
 53-54 S2 p. 189-
1 p.
 article
145 Usefulness of insulin-like growth factor I levels in the diagnosis of growth hormone deficiency in adults Aimaretti, G.
 1998
 53-54 S2 p. 190-
1 p.
 article
146 Visceral obesity and the risk of ischaemic heart disease: insights from the Québec Cardiovascular Study Lamarche, B.
 1998
 53-54 S2 p. 1-8
8 p.
 article
                             146 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands